Molecular bases of NMDA receptor subtype-dependent properties

Journal of Physiology

Volumn 593, Issue 1, 2015, Pages 83-95

  Glasgow, Nathan G ^a   Siegler Retchless, Beth ^a   Johnson, Jon W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN SUBUNIT;

CHEMISTRY; PHYSIOLOGY; PROTEIN SUBUNIT;

PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84920176554     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.273763     Document Type: Article

References (102)

1. Akazawa C, Shigemoto R, Bessho Y, Nakanishi S & Mizuno N (1994). Differential expression of five N-methyl-d-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J Comp Neurol 347, 150-160.
2. 2+ specificity in tetrameric cation channels. Proc Natl Acad Sci U S A 104, 15334-15339.
3. Al-Hallaq RA, Conrads TP, Veenstra TD & Wenthold RJ (2007). NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J Neurosci 27, 8334-8343.
4. Ascher P & Nowak L (1988). The role of divalent cations in the N-methyl-d-aspartate responses of mouse central neurones in culture. J Physiol 399, 247-266.
5. Burnashev N, Schoepfer R, Monyer H, Ruppersberg JP, Gunther W, Seeburg PH & Sakmann B (1992). Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 257, 1415-1419.
6. Burnashev N, Zhou Z, Neher E & Sakmann B (1995). Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol 485, 403-418.
7. Chen N, Luo T & Raymond LA (1999). Subtype-dependence of NMDA receptor channel open probability. J Neurosci 19, 6844-6854.
8. Chen N, Moshaver A & Raymond LA (1997). Differential sensitivity of recombinant N-methyl-d-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol 51, 1015-1023.
9. Chen PE, Geballe MT, Katz E, Erreger K, Livesey MR, O'Toole KK, Le P, Lee CJ, Snyder JP, Traynelis SF & Wyllie DJ (2008). Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol 586, 227-245.
10. 2+ modulation of the NMDA receptor. J Neurosci 21, 392-400.
11. 2+ inhibition of the NMDA receptor. Neuron 23, 171-180.
12. Clarke RJ (2006). NMDA receptor NR2 subunit dependence of the slow component of magnesium unblock. J Neurosci 26, 5825-5834.
13. 2+ unblock. J Neurosci 33, 4140-4150.
14. Clarke RJ & Johnson JW (2008). Voltage-dependent gating of NR1/2B NMDA receptors. J Physiol 586, 5727-5741.
15. Cull-Candy SG & Leszkiewicz DN (2004). Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004, re16.
16. + conduction and selectivity. Science 280, 69-77.
17. Dravid SM, Prakash A & Traynelis SF (2008). Activation of recombinant NR1/NR2C NMDA receptors. J Physiol 586, 4425-4439.
18. Erreger K, Dravid SM, Banke TG, Wyllie DJ & Traynelis SF (2005). Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563, 345-358.
19. Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jorgensen L, Clausen RP, Wyllie DJ, Snyder JP & Traynelis SF (2007). Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-d-aspartate glutamate receptors. Mol Pharmacol 72, 907-920.
20. Erreger K & Traynelis SF (2008). Zinc inhibition of rat NR1/NR2A N-methyl-d-aspartate receptors. J Physiol 586, 763-778.
21. 2+ binding to NMDA receptors. Neuron 25, 683-694.
22. Forsythe ID & Westbrook GL (1988). Slow excitatory postsynaptic currents mediated by N-methyl-d-aspartate receptors on cultured mouse central neurones. J Physiol 396, 515-533.
23. Furukawa H, Singh SK, Mancusso R & Gouaux E (2005). Subunit arrangement and function in NMDA receptors. Nature 438, 185-192.
24. Gallagher MJ, Huang H, Grant ER & Lynch DR (1997). The NR2B-specific interactions of polyamines and protons with the N-methyl-d-aspartate receptor. J Biol Chem 272, 24971-24979.
25. Gielen M, Le Goff A, Stroebel D, Johnson JW, Neyton J & Paoletti P (2008). Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition. Neuron 57, 80-93.
26. Gielen M, Siegler Retchless B, Mony L, Johnson JW & Paoletti P (2009). Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459, 703-707.
27. Gray JA, Shi Y, Usui H, During MJ, Sakimura K & Nicoll RA (2011). Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron 71, 1085-1101.
28. Han X, Tomitori H, Mizuno S, Higashi K, Full C, Fukiwake T, Terui Y, Leewanich P, Nishimura K, Toida T, Williams K, Kashiwagi K & Igarashi K (2008). Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-d-aspartate receptor. J Neurochem 107, 1566-1577.
29. Hansen KB, Ogden KK, Yuan H & Traynelis SF (2014). Distinct functional and pharmacological properties of triheteromeric GluN1/GluN2A/GluN2B NMDA receptors. Neuron 81, 1084-1096.
30. Hardingham GE & Bading H (2010). Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11, 682-696.
31. Hatton CJ & Paoletti P (2005). Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46, 261-274.
32. + channel pore through mutant cycles with a peptide inhibitor. Science 268, 307-310.
33. Humphrey W, Dalke A & Schulten K (1996). VMD: Visual molecular dynamics. J Molecular Graphics 14, 33-38.
34. Johnson JW & Ascher P (1987). Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531.
35. Karakas E & Furukawa H (2014). Crystal structure of a heterotetrameric NMDA receptor ion channel. Science 344, 992-997.
36. Karakas E, Simorowski N & Furukawa H (2009). Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 28, 3910-3920.
37. Karakas E, Simorowski N & Furukawa H (2011). Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 475, 249-253.
38. Kleckner NW & Dingledine R (1988). Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241, 835-837.
39. 2+ block in NMDA receptor channels. J Neurosci 16, 3549-3558.
40. Kussius CL & Popescu GK (2010). NMDA receptors with locked glutamate-binding clefts open with high efficacy. J Neurosci 30, 12474-12479.
41. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M & Mishina M (1992). Molecular diversity of the NMDA receptor channel. Nature 358, 36-41.
42. Lau A & Tymianski M (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 460, 525-542.
43. Lee C-H, Lu W, Michel JC, Goehring A, Du J, Song X & Gouaux E (2014). NMDA receptor structures reveal subunit arrangement and pore architecture. Nature 511, 191-197.
44. Lerma J, Zukin RS & Bennett MV (1990). Glycine decreases desensitization of N-methyl-d-aspartate (NMDA) receptors expressed in Xenopus oocytes and is required for NMDA responses. Proc Natl Acad Sci U S A 87, 2354-2358.
45. Lester RA, Clements JD, Westbrook GL & Jahr CE (1990). Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents. Nature 346, 565-567.
46. Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, Williams K, Traynelis SF & Zheng F (2003). Molecular determinants of proton-sensitive N-methyl-d-aspartate receptor gating. Mol Pharmacol 63, 1212-1222.
47. Low CM, Zheng F, Lyuboslavsky P & Traynelis SF (2000). Molecular determinants of coordinated proton and zinc inhibition of N-methyl-d-aspartate NR1/NR2A receptors. Proc Natl Acad Sci U S A 97, 11062-11067.
48. Luo J, Wang Y, Yasuda RP, Dunah AW & Wolfe BB (1997). The majority of N-methyl-d-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51, 79-86.
49. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ & Barker JL (1986). NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321, 519-522.
50. Maki BA, Aman TK, Amico-Ruvio SA, Kussius CL & Popescu GK (2012). C-terminal domains of N-methyl-d-aspartic acid receptor modulate unitary channel conductance and gating. J Biol Chem 287, 36071-36080.
51. Malenka RC & Bear MF (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5-21.
52. Malherbe P, Mutel V, Broger C, Perin-Dureau F, Kemp JA, Neyton J, Paoletti P & Kew JN (2003). Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket. J Pharmacol Exp Ther 307, 897-905.
53. Martel M-A, Ryan TJ, Bell KFS, Fowler JH, McMahon A, Al-Mubarak B, Komiyama NH, Horsburgh K, Kind PC, Grant SGN, Wyllie DJA & Hardingham GE (2012). The subtype of GluN2 C-terminal domain determines the response to excitotoxic insults. Neuron 74, 543-556.
54. Masuko T, Kashiwagi K, Kuno T, Nguyen ND, Pahk AJ, Fukuchi J, Igarashi K & Williams K (1999). A regulatory domain (R1-R2) in the amino terminus of the N-methyl-d-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol Pharmacol 55, 957-969.
55. 2+ of NMDA responses in spinal cord neurones. Nature 309, 261-263.
56. Mony L, Zhu S, Carvalho S & Paoletti P (2011). Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. EMBO J 30, 3134-3146.
57. Monyer H, Burnashev N, Laurie DJ, Sakmann B & Seeburg PH (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
58. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B & Seeburg PH (1992). Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
59. Ng FM, Geballe MT, Snyder JP, Traynelis SF & Low CM (2008). Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. Mol Brain 1, 16.
60. Nowak L, Bregestovski P, Ascher P, Herbet A & Prochiantz A (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462-465.
61. O'Leary T & Wyllie DJ (2009). Single-channel properties of N-methyl-d-aspartate receptors containing chimaeric GluN2A/GluN2D subunits. Biochem Soc Trans 37, 1347-1354.
62. + channels examined by scanning mutagenesis. J Gen Physiol 117, 345-360.
63. Paoletti P, Ascher P & Neyton J (1997). High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17, 5711-5725.
64. Paoletti P, Bellone C & Zhou Q (2013). NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14, 383-400.
65. Paoletti P, Perin-Dureau F, Fayyazuddin A, Le Goff A, Callebaut I & Neyton J (2000). Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit. Neuron 28, 911-925.
66. Partin KM, Fleck MW & Mayer ML (1996). AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J Neurosci 16, 6634-6647.
67. Perin-Dureau F, Rachline J, Neyton J & Paoletti P (2002). Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 22, 5955-5965.
68. Priestley T, Laughton P, Myers J, Le Bourdelles B, Kerby J & Whiting PJ (1995). Pharmacological properties of recombinant human N-methyl-d-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol Pharmacol 48, 841-848.
69. Punnakkal P, Jendritza P & Kohr G (2012). Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function. Neuropharmacology 62, 1985-1992.
70. Rachline J, Perin-Dureau F, Le Goff A, Neyton J & Paoletti P (2005). The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J Neurosci 25, 308-317.
71. Rambhadran A, Gonzalez J & Jayaraman V (2010). Subunit arrangement in N-methyl-d-aspartate (NMDA) receptors. J Biol Chem 285, 15296-15301.
72. Rauner C & Kohr G (2010). Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-d-aspartate receptor population in adult hippocampal synapses. J Biol Chem 286, 7558-7566.
73. Regalado MP, Villarroel A & Lerma J (2001). Intersubunit cooperativity in the NMDA receptor. Neuron 32, 1085-1096.
74. Riou M, Stroebel D, Edwardson JM & Paoletti P (2012). An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors. PLoS One 7, e35134.
75. Ryan TJ, Kopanitsa MV, Indersmitten T, Nithianantharajah J, Afinowi NO, Pettit C, Stanford LE, Sprengel R, Saksida LM, Bussey TJ, O'Dell TJ, Grant SG & Komiyama NH (2013). Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behaviour. Nat Neurosci 16, 25-32.
76. Salussolia CL, Prodromou ML, Borker P & Wollmuth LP (2011). Arrangement of subunits in functional NMDA receptors. J Neurosci 31, 11295-11304.
77. Schell MJ, Molliver ME & Snyder SH (1995). d-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci U S A 92, 3948-3952.
78. 2+ influx and reversal potentials in recombinant N-methyl-d-aspartate receptor channels. Biophys J 70, 2165-2174.
79. Schorge S, Elenes S & Colquhoun D (2005). Maximum likelihood fitting of single channel NMDA activity with a mechanism composed of independent dimers of subunits. J Physiol 569, 395-418.
80. Schreiber G & Fersht AR (1995). Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. J Mol Biol 248, 478-486.
81. Sheng M, Cummings J, Roldan LA, Jan YN & Jan LY (1994). Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368, 144-147.
82. +-conducting channel. Nature 440, 570-574.
83. Siegler Retchless B, Gao W & Johnson JW (2012). A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction. Nat Neurosci 15, 406-413.
84. Sobolevsky AI, Rosconi MP & Gouaux E (2009). X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462, 745-756.
85. Stroebel D, Carvalho S & Paoletti P (2011). Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain. Neuropharmacology 60, 151-158.
86. Swanson GT & Heinemann SF (1998). Heterogeneity of homomeric GluR5 kainate receptor desensitization expressed in HEK293 cells. J Physiol 513, 639-646.
87. Tikhonov DB (2007). Ion channels of glutamate receptors: structural modeling. Mol Membr Biol 24, 135-147.
88. Tovar KR, McGinley MJ & Westbrook GL (2013). Triheteromeric NMDA receptors at hippocampal synapses. J Neurosci 33, 9150-9160.
89. Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P & Powers JL (1998). Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 18, 6163-6175.
90. Traynelis SF, Hartley M & Heinemann SF (1995). Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268, 873-876.
91. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ & Dingledine R (2010). Glutamate receptor ion channels: Structure, regulation, and function. Pharmacol Rev 62, 405-496.
92. Vance KM, Hansen KB & Traynelis SF (2012). GluN1 splice variant control of GluN1/GluN2D NMDA receptors. J Physiol 590, 3857-3875.
93. Varney MA, Jachec C, Deal C, Hess SD, Daggett LP, Skvoretz R, Urcan M, Morrison JH, Moran T, Johnson EC & Velicelebi G (1996). Stable expression and characterization of recombinant human heteromeric N-methyl-d-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells. J Pharmacol Exp Ther 279, 367-378.
94. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB & Grayson DR (1998). Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors. J Neurophysiol 79, 555-566.
95. Williams K (1993). Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44, 851-859.
96. Williams K (1996). Separating dual effects of zinc at recombinant N-methyl-d-aspartate receptors. Neurosci Lett 215, 9-12.
97. Wood MW, VanDongen HMA & VanDongen AMJ (1995). Structural conservation of ion conduction pathways in K channels and glutamate receptors. Proc Natl Acad Sci U S A 92, 4882-4886.
98. 2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol 586, 211-225.
99. Wyllie DJ, Behe P & Colquhoun D (1998). Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J Physiol 510, 1-18.
100. Yuan H, Hansen KB, Vance KM, Ogden KK & Traynelis SF (2009). Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 29, 12045-12058.
101. Yuan H, Hansen KB, Zhang J, Pierson TM, Markello TC, Fajardo KV, Holloman CM, Golas G, Adams DR, Boerkoel CF, Gahl WA & Traynelis SF (2014). Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy. Nat Commun 5, 3251.
102. Zhou Q & Sheng M (2013). NMDA receptors in nervous system diseases. Neuropharmacology 74, 69-75.